MDGL
Madrigal Pharmaceuticals Inc
513.20$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -86.7% | – | – | – | +252.0% | +5,416.1% | -89.7% | -48.8% | -98.1% | -100.0% | – | – | – | – | -100.0% | – | – | – | – | – | – | +432.1% | |
| – | – | – | – | – | – | – | – | – | – | – | -49.6% | -30.1% | +30.4% | -100.0% | – | +49,259.0% | +24.7% | +16.7% | +320.5% | -14.0% | +15.3% | +12.8% | +1,082.7% | +800.8% | |
| – | – | – | -326.8% | – | – | – | +252.0% | +5,274.6% | -89.5% | -58.7% | -112.1% | – | – | – | – | – | -127.4% | – | – | – | – | – | – | +418.8% | |
| – | +2,532.5% | +233.7% | +56.7% | +57.1% | -15.7% | +3.0% | +56.8% | -37.4% | -21.2% | +3.0% | +19.2% | +45.4% | -5.1% | -20.5% | -70.6% | +53.1% | +4.1% | +184.9% | +155.5% | +11.0% | +19.6% | +11.0% | -13.1% | +64.1% | |
| – | – | – | – | – | – | +72.7% | -1.3% | -14.2% | -9.5% | +0.9% | +1.1% | +34.5% | +0.3% | -14.9% | -30.6% | -17.4% | +99.3% | +48.1% | -3.5% | +70.7% | +29.0% | +124.7% | +302.3% | +87.1% | |
| – | +1,718.5% | +305.9% | +48.6% | +56.3% | -19.2% | +14.6% | +51.1% | -36.3% | -18.7% | +3.6% | +17.1% | +44.2% | -4.3% | -96.2% | +695.5% | +27.1% | +26.9% | +133.4% | +117.6% | +17.3% | +21.1% | +29.6% | +76.6% | +79.0% | |
| – | – | – | – | – | – | – | – | – | -145.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -36.2% | +82.4% | +242.4% | -5.1% | +42.4% | -16.1% | -52.0% | +9.7% | -52.1% | +1,274.7% | +43.7% | -60.7% | -76.0% | +280.8% | +220.7% | +15.4% | +52.1% | |
| – | – | – | – | – | – | – | – | – | -147.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4,876.4% | – | – | -494.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -241.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -147.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -352.8% | – | – | – | – | – | – | -142.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.